- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06893471
From Yearly Checks to Daily Progress: Evaluating Goal Attainment Scaling (GAS) in Systematic Work Environment Management (SAM) Within the Municipal Sector (GAS for SAM)
From Annual Measurements to Daily Improvements: Evaluation of a Method for Improving Systematic Work Environment Management
The goal of this project is to evaluate a practical method for improving systematic work environment management (SAM) by focusing on health-promoting factors rather than identifying risk-factors, and deficiencies. It will also explore how Goal Attainment Scaling (GAS) can support goal-setting and evaluation within SAM. The main questions it aims to answer are:
- Which health-promoting factors are prioritized, and what organizational-level initiatives are developed?
- How does using GAS influence goal achievement related to health-promoting factors?
- How do employees, managers, and HR representatives perceive the use of GAS?
- What factors help or hinder the implementation of GAS and goal attainment?
Participants will:
Apply GAS within their organizations to set and evaluate goals Engage in a participatory process to identify key health-promoting factors Assess progress and the impact of interventions over time Researchers will analyze the effectiveness of GAS in enhancing SAM (experiment vs control group) and develop tools to support sustainable, healthy workplaces in the municipal sector.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This project aims to test and evaluate a practical method for enhancing systematic work environment management (SAM), shifting the focus from identifying deficiencies to achieving goals centered on health-promoting factors. Competence supply is one of the greatest challenges for Swedish municipalities, and deficiencies in organizational and social work environments contribute significantly to sickness absence, poor mental health, and well-being. This issue threatens municipalities' ability to fulfill their responsibilities to citizens. Active systematic work environment management (SAM) has been identified as a potential solution, yet many municipalities rely on annual assessments focused on shortcomings, without providing indicators for concrete solutions, goal achievement, or measurable progress.
There is a lack of knowledge on how SAM should be designed to prioritize health-promoting factors (i.e., workplace conditions that support employee health and sustainable employment) at an organizational level. Additionally, there is a need for goal indicators that are motivating, measurable, and applicable at both unit and organizational levels.
To address these pressing needs, we propose applying the Goal Attainment Scaling (GAS) method. GAS serves as both a goal-setting and evaluation methodology, previously applied successfully at the individual level. We suggest that GAS can help organizations formulate concrete and tailored desired states related to specific interventions, thereby enhancing improvements in health-promoting factors.
GAS offers several advantages for enhancing SAM. First, goal-setting theory suggests that GAS facilitates the establishment of achievable and relevant goals. A participatory design is crucial, fostering a shared mental model of objectives. Second, GAS promotes data-driven decision-making and accountability within SAM, enabling workplaces to systematically assess progress and the impact of work environment initiatives. Third, GAS is versatile and universal, serving as a general framework adaptable to different organizations and their specific contexts and objectives.
The project will address the following research questions:
- Which health-promoting factors are prioritized, and what organizational-level initiatives are generated to address them?
- How does the application of GAS (as part of SAM) influence the achievement of goals related to health-promoting factors?
- How is the use of GAS perceived by different stakeholders (employees, managers, HR representatives)?
- What facilitators and barriers influence the implementation of GAS and the attainment of goals? The project will identify and highlight prioritized organizational-level health-promoting factors while mapping successful strategies and practices for addressing them. The expected outcome is the development of a systematic, participatory, and practical method that fosters local engagement in initiative development, goal setting, and follow-up of health-promoting factors within SAM. This work will contribute to the development of measurement methods and outcome metrics for organizational-level health-promoting factors. The resulting knowledge and tools can support the creation of long-term healthy, sustainable, and attractive workplaces within the municipal sector
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gävleborg County
-
Hudiksvall, Gävleborg County, Sweden, 824 91
- Hudiksvall municipality
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- work unit must have >3 employees, working within municipal sector, no other major organizational changes
Exclusion Criteria:
- Units with <3 employees, other major organizational changes
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
Business-as-usual condition: This group follows established processes for systematic work engagement management (SAM) We will employ a randomization approach using a two-arm stepped-wedge design. This design allows for a sequential roll-out of the intervention across study arms while maintaining a randomized allocation schedule. The stepped-wedge approach ensures that all participants eventually receive the intervention, while still permitting valid between-group comparisons at different time points. Importantly, this design also enables the inclusion of an additional measurement point, which will strengthen our ability to assess both short-term and longer-term intervention effects. |
|
|
Experimental: Experiment group
Works with Goal Attainment Scaling (GAS) as part of systematic work engagement management (SAM) We will employ a randomization approach using a two-arm stepped-wedge design. This design allows for a sequential roll-out of the intervention across study arms while maintaining a randomized allocation schedule. The stepped-wedge approach ensures that all participants eventually receive the intervention, while still permitting valid between-group comparisons at different time points. Importantly, this design also enables the inclusion of an additional measurement point, which will strengthen our ability to assess both short-term and longer-term intervention effects. |
This study adapts Goal Attainment Scaling (GAS) for group-level goal setting within systematic work environment management. Developed collaboratively with organizational stakeholders, the method is: Tailormade - Allows flexibility in defining and scaling goals. Co-created - Encourages ownership and employee involvement. Standardized - Uses a five-level scale (-2 to +2) for tracking progress and enabling comparisons. Data-driven - Includes a Progress Graph for systematic follow-up and documentation of goals and initiatives. Managers in the experiment group will receive training before implementation begins |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Employee survey results
Time Frame: From enrollment to the end of treatment at 2 years
|
The results from the annual employee survey will be the primary outcome in this study. The municipality uses e.g., HME index from Sveriges Kommuner och Regioner (SKR) and are developing specific items for measuring health factors built on research based questions.
COPSOQIII Responses are rated on a five point (1-5) Likert-scale (higher score better outcome) |
From enrollment to the end of treatment at 2 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Ulrica von Thiele Schwarz, Professor in Psychology, Mälardalen University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Behavioral Symptoms
- Stress, Psychological
- Occupational Diseases
- Behavior
- Occupational Stress
- Amino Acids, Peptides, and Proteins
- Sulfur Compounds
- Organic Chemicals
- Heterocyclic Compounds
- Heterocyclic Compounds, 2-Ring
- Heterocyclic Compounds, Fused-Ring
- Nucleic Acids, Nucleotides, and Nucleosides
- Purines
- Amino Acids
- Nucleosides
- Ribonucleosides
- Amino Acids, Sulfur
- Adenosine
- Purine Nucleosides
- Methionine
- S-Adenosylmethionine
Other Study ID Numbers
- 20240063 (AFA-grant)
- 20240063 (Other Grant/Funding Number: AFA-insurance)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Behavior Change Interventions
-
Medical University of GrazCompletedBehavior Change Interventions | PRF | Implant DentistryAustria
-
University College DublinPLAN'EAT Consortium (https://planeat-project.eu/)Active, not recruitingBehavior Change | Dietary Behaviour | Behavior Change Interventions | Behavior And Behavior Mechanism | Sustainable Healthy Diet | Personalised NutritionIreland
-
Dream Video LLCDream Holdings ResearchNot yet recruitingMemory | Habits | Behavior Change Interventions | Memory Encoding
-
Colorado State UniversityNational Cancer Institute (NCI)RecruitingPhysical Activity Behavior | Behavior Change Interventions | Exercise OncologyUnited States
-
University of South WalesPublic Health Wales; Cwm Taf University Health Board (NHS)SuspendedCardiovascular Diseases | Cardiovascular Risk Factor | Behavior, Health | Behavior Change InterventionsUnited Kingdom
-
Chinese University of Hong KongNot yet recruiting
-
Charite University, Berlin, GermanyUniversitat Internacional de CatalunyaRecruitingSexual Behavior | Behavior Problems | Prevention | Behavioral Disorder | Well Being | Behavior Change | Behavior Change Interventions | Child Sexual Abuse Material (CSAM) Consumption | Online BehaviourGermany, Spain
-
Geisinger ClinicRecruitingEmergency Service, Hospital | Behavior Change InterventionsUnited States
-
Saglik Bilimleri UniversitesiCompletedPregnancy | Climate ChangeTurkey (Türkiye)
-
Fundació Sant Joan de DéuInstitut National de la Santé Et de la Recherche Médicale, France; Klaipėda... and other collaboratorsRecruitingPhysical Activity | Health Promotion | Health Education | Nutrition | Behaviour ChangeSpain
Clinical Trials on GAS for SAM
-
Victor M. AguayoGandhi Medical College, Bhopal; Bundelkhand Medical College, Sagar, Madhya... and other collaboratorsCompletedSevere MalnutritionIndia
-
University of HawaiiCompleted
-
Children's Hospital and Institute of Child Health...CompletedChildren | Severe Acute Malnutrition | Persistent DiarrheaPakistan
-
University of DelawareUniversity of Pennsylvania; Christiana Care Health Services; Indiana UniversityCompleted
-
Ismail Erkan AydinCompleted
-
PfizerCompleted
-
M.D. Anderson Cancer CenterAstraZenecaRecruitingAdenoid Cystic CarcinomaUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAlzheimer DiseaseNetherlands
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedAlzheimer DiseaseFrance
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted